Project Details
Description
To build on discoveries on new biomarkers in at-risk eyes with Diabetic Macular Oedema (DMO). Visual acuity (VA) is a poor indicator to describe functional impairment in DMO. DMO near the fovea may be sight-threatening bu is not flagged by VA. Multifocal Pupillographic Objective Perimetry (mfPOP) has advanced the objective assessment of macular function and has made it possible to evaluate retinal sensitivity in eyes at risk of vision loss from very early-stage diabetic retinopathy.
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/20 → 31/12/20 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.